Geriatric Oncology Workshop

Loneliness and social isolation in older patients with cancer:

Chemotherapy related cognitive decline: Associated factors and management

Panel DIscussion Shared decision making in older patients with cancer: implementation and challenges

Digital Health with AI in geriatric oncology-new possibilities

Analgesia in older patients with cancer

Panel Discussion: Management issues in an older patient with cancer

Conclusion and vote of thaWelcome & Introductionnks

Welcome & Introduction

Surgical Video Session

Early Stage Lung Cancer: VATS Lobectomy for early stage lung cancer - video

Locally Advanced: VATS Lobectomy post immunotherapy

Evolution of HITHOC in intrathoracic malignancies

HITHOC - Video

Malignant pleural effusion - IPC vs ICD. When to do pleurodesis Indian context. Literature

Surgical Options - Oligometastatic - Videos

1. Epidemiology and Screening: OA01.01 Genetic and Air Pollution Score Identify Individual at Elevated Risk in a Lung Cancer Screening Cohort

Integration of Screening for Lung Cancer in South East Asian Perspective: Challenges and Way Forward

2. Early Stage Lung Cancer: · PL03.13 Survival Outcome of VATS Compared to Open Lobectomy for Lung Cancer: An Individual Patient Data Meta-analysis of Randomized Trial

P1.07.10 Prognostic Impact of Resection Margin Distance in Patients With Completely Resected Stage I NSCLC After Lobectomy

P1.07.24 Radicality of Lymphadenectomy in NSCLC Resection: Impact on Survival. Results From the Spani h Video-A i ted Thoracic Surgery Group (GEVATS)

P1.07.26 Applicability of Artificial Intelligence Based Tumor Segmentation in Planning for Sublobar Resection in Lung Cancer: A Meta-Analysis

PL03.10 Adjuvant Chemotherapy (CT) v CT-immunotherapy for R0 Stage IB-IIIA NSCLC Patient (NADIM ADJUVANT): a Randomized, Phase 3 Trial

OA02.03 Overall Survival (OS) with Neoadjuvant Nivolumab Plus Chemotherapy by Surgical Outcome in the Phase 3 CheckMate 816 Study

MA01.04 Neoadjuvant PD-(L)1 Blockade in Combination With Chemotherapy for Borderline resectable and unresectable Stage III Non-Small Cell Lung Cancer

MA01.05 Tislelizumab Plus Chemotherapy Followed by Surgery or Radiotherapy and Adjuvant Tislelizumab in Unresectable Stage III NSCLC

Perioperative pembrolizumab in early-stage non-small- cell lung cancer (NSCLC): 5-year follow-up from KEYNOTE- 671

NeoADAURA: Neoadjuvant osimertinib in EGFR-mutated early-stage NSCLC.

The Emerging Role of Antibody Drug Conjugates in Lung Cancer

Radiotherapy in Locally advanced NSCLC: P3.18.17 Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer (NeoRADjuvant)

P3.12.37 First-Line Lazertinib With or Without Local Ablative Radiotherapy in Oligo-Metastatic EGFR- Mutant NSCLC

Consolidative Radiotherapy with Osimertinib in Advanced EGFR-Mutant Non-Small Cell Lung Cancer: Long-Term Local and Intracranial Control Results from a Phase II Trial

Ten-Year Outcomes of the Revised STARS Trial Comparing Radiation and Surgery for Early-Stage Non-Small Cell Lung Cancer

P3.13.27 Toripalimab Consolidation After Chemoradiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase II, Randomized Controlled Study

Baseline and Time-Dependent Predictors of Cognitive Decline for Brain Metastasis Patients Treated with Radiotherapy– A Secondary Analysis of the ATHENA Trial

Panel Discussion: Based on the Above Abstracts

4. Advanced Lung Cancer - Driver mutation negative NSCLC: 4. Advanced Lung Cancer - Driver mutation negative NSCLC

OA05.01 ASTRUM-002: First-Line Serplulimab Plus Chemotherapy With or Without HLX04 in Advanced Non-squamous Non-Small Cell Lung Cancer

First-line pembrolizumab for metastatic NSCLC in lower-middle-income countries: bridging the efficacy-effectiveness gap

5. Oligometastatic NSCLC: Consolidative Hypofractionated RT for Oligometastatic NSCLC

ndividualized SBRT for Ultra-Central NSCLC Achieves Optimal Tumor Control With Minimal Toxicity

Abstract - CURB Trial

TIL Therapy in Melanoma

TIL Therapy in Cervical Cancer

TIL Panel Discussion

CAR-T in Gastric cancers

CAR-T in Glioblastoma

CAR-T in Midline Glioma

CAR-T in Neuroblastoma

New Proven Data in CART

Panel Discussion: CAR-T

TCR-T in Synovial Sarcoma

TCR-T in other solid tumours